Terns Pharmaceuticals, Inc. financial data

Symbol
TERN on Nasdaq
Location
1065 East Hillsdale Blvd., Suite 100, Foster City, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.74K % +18.4%
Debt-to-equity 4.49 % -10.6%
Return On Equity -27.4 % +30.9%
Return On Assets -26.2 % +30.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 87.5M shares +24.4%
Common Stock, Shares, Outstanding 87.5M shares +24.4%
Common Stock, Value, Issued 9K USD +28.6%
Weighted Average Number of Shares Outstanding, Basic 91.6M shares +23%
Weighted Average Number of Shares Outstanding, Diluted 91.6M shares +23%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 33.5M USD -14.2%
Costs and Expenses 106M USD -2.34%
Operating Income (Loss) -106M USD +2.34%
Nonoperating Income (Expense) 14.2M USD +12.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -91.5M USD +4.33%
Income Tax Expense (Benefit) 254K USD -4.15%
Net Income (Loss) Attributable to Parent -91.7M USD +4.33%
Earnings Per Share, Basic -1 USD/shares +22%
Earnings Per Share, Diluted -1 USD/shares +22%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 146M USD +59.5%
Marketable Securities, Current 169M USD +26.7%
Assets, Current 319M USD +38.5%
Property, Plant and Equipment, Net 70K USD -81.1%
Operating Lease, Right-of-Use Asset 1.04M USD +378%
Other Assets, Noncurrent 356K USD +547%
Assets 320M USD +38.8%
Accounts Payable, Current 2.85M USD +52.1%
Employee-related Liabilities, Current 3.22M USD +3.44%
Liabilities, Current 12.9M USD +17.9%
Accrued Income Taxes, Noncurrent 1.58M USD +27.3%
Operating Lease, Liability, Noncurrent 689K USD
Liabilities 15.2M USD +24.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -22K USD +95%
Retained Earnings (Accumulated Deficit) -469M USD -24.3%
Stockholders' Equity Attributable to Parent 305M USD +39.6%
Liabilities and Equity 320M USD +38.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -24.4M USD -7.2%
Net Cash Provided by (Used in) Investing Activities 1.96M USD -75.5%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 87.5M shares +24.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -22.4M USD -51.2%
Deferred Tax Assets, Valuation Allowance 78.2M USD +31.2%
Deferred Tax Assets, Gross 620K USD +241%
Operating Lease, Liability 1.13M USD +355%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -91.3M USD +4.44%
Lessee, Operating Lease, Liability, to be Paid 1.28M USD +407%
Property, Plant and Equipment, Gross 2.11M USD -0.05%
Operating Lease, Liability, Current 444K USD +78.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +66.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 144K USD +4700%
Deferred Tax Assets, Operating Loss Carryforwards 28M USD +40.5%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 5.54M USD -26.2%
Additional Paid in Capital 775M USD +29.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 55K USD -32.9%
Share-based Payment Arrangement, Expense 13.9M USD -46.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%